Head-to-head · Cost-Efficiency Index
Ondra Health vs bmiMD
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Ondra Health
Value shoppers who want one of the lowest disclosed prices on both molecules without giving up nationwide access or pharmacy verification.
Visit Ondra HealthbmiMD
Price-driven shoppers who want both molecules cheap and nationwide and will vet the pharmacy themselves.
Visit bmiMDThe verdict
Ondra Health takes it, leading the Cost-Efficiency Index 90 to 84. A rare combination — near-rock-bottom pricing on both molecules, all-50 access, brand-name availability, and a LegitScript-verified pharmacy behind it. bmiMD still earns a B — Price-driven shoppers who want both molecules cheap and nationwide and will vet the pharmacy themselves.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Ondra Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Ondra Health | bmiMD |
|---|---|---|
| Cost-Efficiency Index | 90/100 | 84/100 |
| Semaglutide / mo | $93/mo | $99/mo |
| Tirzepatide / mo | $166/mo | $139/mo |
| Semaglutide / yr (modeled) | $1,116 | $1,188 |
| Tirzepatide / yr (modeled) | $1,992 | $1,668 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank on the board | #2 | #18 |
Ondra Health
90/100Where the value is
- Among the lowest disclosed prices on the board — $93 semaglutide and $166 tirzepatide
- Available in all 50 states with both molecules published for clean cost modeling
- LegitScript-certified, and offers FDA-approved brand-name access alongside compounded
The tradeoffs
- A newer, lower-profile operator without CoreAge's long flat-price track record
- No oral/sublingual route
bmiMD
84/100Where the value is
- Very low prices on both molecules — $99 semaglutide / $139 tirzepatide
- Nationwide all-50 access with both molecules disclosed
- Strong raw cost-per-month
The tradeoffs
- Not LegitScript-certified
- Compounded only — no oral or brand option
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.